A detailed history of International Biotechnology Trust PLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 46,092 shares of KRYS stock, worth $7.41 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares
46,092
Previous 45,945 0.32%
Holding current value
$7.41 Million
Previous $5.39 Million 0.87%
% of portfolio
1.81%
Previous 1.68%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$108.51 - $130.22 $15,950 - $19,142
147 Added 0.32%
46,092 $5.35 Million
Q2 2023

Aug 08, 2023

SELL
$78.48 - $130.32 $1.18 Million - $1.96 Million
-15,055 Reduced 24.68%
45,945 $5.39 Million
Q1 2023

May 18, 2023

BUY
$72.39 - $84.27 $1.16 Million - $1.35 Million
16,000 Added 35.56%
61,000 $4.88 Million
Q3 2022

Nov 08, 2022

BUY
$64.85 - $82.4 $2.73 Million - $3.46 Million
42,045 Added 1422.84%
45,000 $3.13 Million
Q2 2022

Aug 16, 2022

SELL
$48.93 - $73.47 $2.06 Million - $3.09 Million
-42,045 Reduced 93.43%
2,955 $45 Million
Q4 2021

Feb 15, 2022

BUY
$39.81 - $88.24 $1.79 Million - $3.97 Million
45,000 New
45,000 $3.15 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.13B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.